Skip to main content
HLB Genex, Inc. logo

HLB Genex, Inc. — Investor Relations & Filings

Ticker · 187420 ISIN · KR7187420005 KO Manufacturing
Open in API
Filings indexed 260 across all filing types
Latest filing 2026-05-14 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 187420

About HLB Genex, Inc.

http://hlbgenex.com/

HLB Genex, Inc. is a biotechnology company that develops and produces customized enzyme and microbiome-based solutions. The company's core activities involve the research, development, and manufacturing of industrial special enzymes and bio-healthcare ingredients. Its key products include enzymes like Lactase for food applications, Catalase for eco-friendly industrial processes, and Proteinase K for molecular diagnostics. In the bio-healthcare segment, it produces Vitamin K2 (Menaquinone 7) for bone and cardiovascular health and Phytosphingosine for cosmeceuticals. The company utilizes proprietary platform technologies, such as Microbial Surface Display and Spore Biologics, to develop its products and advance its pipeline of microbiome therapeutics by identifying effector molecules, also known as postbiotics.

Recent filings

Filing Released Lang Actions
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 95% confidence The provided document is labeled as “분기보고서 (제27기) 2026년 01월 01일 – 2026년 03월 31일,” which translates to a Quarterly Report (Form 10-Q equivalent) for the first quarter of 2026. It is over 250,000 characters long and contains comprehensive financial data, corporate overviews, segment reporting, capital changes, stock information, product and operational details, and actual financial statements prepared under K-IFRS. This is not merely a publication notice or a certification, but the full interim financial report itself. Therefore, it should be classified as an Interim / Quarterly Report (IR). Q1 2026
2026-05-14 Korean
전환청구권행사
Share Issue/Capital Change Classification · 88% confidence The document is a regulatory announcement detailing the exercise of conversion rights on the company’s convertible bonds, including the number of shares to be issued, conversion prices, and related issuance details. This constitutes a capital change through the issuance of new shares. Therefore, it falls under the “Share Issue/Capital Change” category (SHA).
2026-04-28 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 90% confidence The document is titled “임원·주요주주 특정증권등 소유상황보고서” and details the holdings and changes in ownership of company shares by an executive (reporting person 김도연), including specific share counts and transaction dates. This matches an insider transaction report of a director or major shareholder. Therefore, it is classified as a Director’s Dealing report (DIRS).
2026-04-22 Korean
전환청구권행사
Share Issue/Capital Change Classification · 85% confidence The document is a corporate disclosure regarding the exercise of convertible bond conversion rights, detailing the number of shares issued, total share count, and remaining bond balance. This is an announcement of a change in capital structure through new share issuance upon conversion. Hence it falls under “Share Issue/Capital Change” (SHA).
2026-04-21 Korean
[기재정정]전환청구권행사
Share Issue/Capital Change Classification · 85% confidence The document is a regulatory disclosure concerning the exercise of convertible bond conversion rights (“전환청구권 행사”), including corrected listing dates and details of share issuance from bond conversions. It reports capital structure changes (new shares issued upon conversion), not a full financial report. This falls under Share Issue/Capital Change (SHA).
2026-04-21 Korean
[기재정정]전환청구권행사
Share Issue/Capital Change Classification · 90% confidence The document is a Korean regulatory announcement detailing the exercise of conversion rights on convertible bonds, the cumulative number of shares issued, and a corrected listing date. It reports the issuance of new shares upon bond conversion, constituting a change in share capital. This fits the “Share Issue/Capital Change” category (SHA) rather than a general financing update or other type.
2026-04-21 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.